1.A Case of Primary Infective Endocarditis Caused by Community-Associated Methicillin-Resistant Staphylococcus aureus in a Healthy Individual and Colonization in the Family.
Seo Young LEE ; Jin Yong KIM ; Jin Hee KIM ; Sue Yun KIM ; Chulmin PARK ; Yoon Soo PARK ; Yiel Hae SEO ; Yong Kyun CHO
Yonsei Medical Journal 2009;50(1):152-155
Primary community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) endocarditis has rarely been reported in healthy individuals without risk factors, such as skin and soft tissue infections, and intravenous drug abuse. We describe a case of infective endocarditis by CA-MRSA (ST72-PVL negative-SCCmec IVA) in previously healthy individuals with no underlying medical condition and CA-MRSA colonization in the family.
Adult
;
Community-Acquired Infections/microbiology/transmission
;
Endocarditis/*microbiology
;
Family
;
Female
;
Humans
;
*Methicillin Resistance
;
Staphylococcal Infections/*diagnosis/drug therapy/*transmission
;
Staphylococcus aureus/*drug effects
2.A rare case of community acquired Burkholderia cepacia infection presenting as pyopneumothorax in an immunocompetent individual.
Suman S KARANTH ; Hariharan REGUNATH ; Kiran CHAWLA ; Mukhyaprana PRABHU
Asian Pacific Journal of Tropical Biomedicine 2012;2(2):166-168
Burkholderia cepacia (B. cepacia) infection is rarely reported in an immunocompetent host. It is a well known occurence in patients with cystic fibrosis and chronic granulomatous disease where it increases both morbidity and mortality. It has also been included in the list of organisms causing nosocomial infections in an immunocompetent host, most of them transmitted from the immunocompromised patient in which this organism harbors. We report a rare case of isolation of B. cepacia from the bronchoalveolar lavage fluid of an immunocompetent agriculturist who presented with productive cough and fever associated with a pyopneumothorax. This is the first case of community acquired infection reported in an immunocompetent person in India.
Adult
;
Anti-Bacterial Agents
;
therapeutic use
;
Azithromycin
;
therapeutic use
;
Bronchoalveolar Lavage Fluid
;
microbiology
;
Burkholderia Infections
;
diagnosis
;
drug therapy
;
transmission
;
Burkholderia cepacia
;
drug effects
;
isolation & purification
;
Ceftazidime
;
therapeutic use
;
Ceftizoxime
;
therapeutic use
;
Community-Acquired Infections
;
diagnosis
;
drug therapy
;
Drug Resistance, Multiple, Bacterial
;
Humans
;
Immunocompetence
;
India
;
Male
;
Pneumothorax
;
complications